SECsense Logo

Mineralys Therapeutics, Inc. 8-K Report: Key Updates from January 8, 2025

$MLYS
Form 8-K
Filed on: 2025-01-08
Source
Mineralys Therapeutics, Inc. 8-K Report: Key Updates from January 8, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: January 8, 2025
  1. Company Details:
  • Company Name: Mineralys Therapeutics, Inc.
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001933414
  • IRS Employer Identification Number (EIN): 84-1966887
  • Address: 150 N. Radnor Chester Road, Suite F200, Radnor, PA 19087
  • Phone Number: 888-378-6240
  1. Stock Information:
  • Common Stock Par Value: $0.0001 per share
  • Ticker Symbol: MLYS
  • Exchange: NASDAQ
  1. Filing Context:
  • Period: The report refers to a specific date, January 8, 2025, indicating that this filing may be related to an event or information that occurred on that date.

Insights:

  • This filing is an 8-K, which is typically used to report major events that shareholders should know about, such as acquisitions, bankruptcy, or changes in management.
  • The company is publicly traded on NASDAQ, which provides a platform for evaluating its market performance.
  • The address and contact information may be useful for investors or analysts wishing to reach out for further inquiries or information.

Overall, this filing indicates that significant information regarding Mineralys Therapeutics, Inc. was disclosed on January 8, 2025, which could be important for stakeholders and investors to monitor.